These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20037444)

  • 1. [A case report of un-resectable pancreas body carcinoma successfully treated by chemoradiotherapy].
    Nagahama T; Ando M; Ohara T; Ganno H; Hataji K; Ami K; Fukuda A; Maruyama M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2425-7. PubMed ID: 20037444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
    Yamazaki H; Nishiyama K; Koizumi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):216-9. PubMed ID: 15211883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low-dose gemcitabine concurrent with radiation therapy for locally advanced pancreatic carcinoma].
    Baba H; Kurata M; Tsuruta K; Okamoto A; Karasawa K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1863-5. PubMed ID: 17212129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
    Girard N; Mornex F; Bossard N; Ychou M; Chauffert B; Wautot V
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1426-32. PubMed ID: 20056351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
    Ohta H; Doi T; Kikuchi S; Sato Y; Okuda T; Fujimi A; Kanisawa Y; Izumi K; Kitahara T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1489-92. PubMed ID: 17876153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
    McGinn CJ; Lawrence TS; Zalupski MM
    Cancer; 2002 Aug; 95(4 Suppl):933-40. PubMed ID: 12209674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer.
    Youl M; Hashem S; Brade A; Cummings B; Dawson LA; Gallinger S; Hedley D; Jiang H; Kim J; Krzyzanowska MK; Ringash J; Wong R; Brierley J
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):203-9. PubMed ID: 24462333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined systemic and intraarterial chemotherapy with gemcitabine and concomitant external-beam radiotherapy in patients with liver metastasis from pancreatic cancer--report of two cases].
    Matsugu Y; Tanaka T; Kagawa N; Nakahara H; Ishimoto T; Fukuda Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1489-92. PubMed ID: 16227756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
    Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
    Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
    J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.
    Ogawa K; Ito Y; Hirokawa N; Shibuya K; Kokubo M; Ogo E; Shibuya H; Saito T; Onishi H; Karasawa K; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):559-65. PubMed ID: 22019243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.
    Budiharto T; Haustermans K; Van Cutsem E; Van Steenbergen W; Topal B; Aerts R; Ectors N; Bielen D; Vanbeckevoort D; Goethals L; Verslype C
    Radiat Oncol; 2008 Sep; 3():30. PubMed ID: 18808686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer.
    Furuse J; Ishii H; Kawashima M; Nagase M; Nihei K; Nakachi K; Ogino T; Yoshino M
    Hepatogastroenterology; 2007; 54(77):1575-8. PubMed ID: 17708303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
    Ohmura Y; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Monden M; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2428-9. PubMed ID: 20037445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.
    Igarashi H; Ito T; Kawabe K; Hisano T; Arita Y; Kaku T; Takayanagi R
    World J Gastroenterol; 2008 Sep; 14(34):5311-5. PubMed ID: 18785284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.
    Brasiūniene B; Juozaityte E
    Medicina (Kaunas); 2007; 43(9):716-25. PubMed ID: 17986845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].
    Brasiūniene B; Brasiūnas V; Juozaityte E
    Medicina (Kaunas); 2006; 42(10):817-22. PubMed ID: 17090981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement.
    Nagakawa Y; Hosokawa Y; Nakayama H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasuya K; Katsumata K; Tokuuye K; Tsuchida A
    Cancer Chemother Pharmacol; 2017 May; 79(5):951-957. PubMed ID: 28378027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gemcitabine concurrent with radiation for locally advanced pancreatic cancer].
    Baba H; Suzuki Y; Ema T; Kawakami M; Nakanishi C; Hashimoto T; Arai T; Matsumoto G; Tsuruta K; Okamoto A; Karasawa K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1730-2. PubMed ID: 16315923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy.
    Kamachi H; Tsuruga Y; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamiyama T; Katoh N; Taketomi A
    In Vivo; 2018; 32(5):1183-1191. PubMed ID: 30150442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.